Book a call

    Client testimonials

    “Leonardo's deep, complementary expertise in life sciences and capital gave my thinking real structure and direction. He helped me see where the real value sat and how to build the infrastructure around it.”

    Lili Troshina

    Strategy & Growth Leader; Femtech Longevity expert platform founder.

    “Instrumental in refining our long-term strategy. Leonardo transformed my perspective on growth by showing that even the most innovative medical technology needs a robust plan to succeed. His ability to bridge complex science and market viability is rare and invaluable.”

    Clarissa Meneghini

    Sales Manager for Exoskeletons in Healthcare.

    “An exceptionally capable and analytical manager with a deep understanding of the biotech and venture capital industry.”

    Jacopo Franchini

    Strategic Marketing Advisor, Recordati Rare Diseases.

    “A fantastic team player and natural leader who bridges science and business in pharma/biotech.”

    Francesco Grillo

    Start-up & Portfolio Manager, Max Planck Innovation.

    “A fantastic professional and strategic thinker who turns advances into real opportunities for business development.”

    Fabrizio Bianchi

    Head, Cancer Biomarkers Unit, Fondazione Casa Sollievo della Sofferenza.

    “He has an inspiring collaborative leadership style, with nuanced international expertise and diplomacy.”

    Anne-Marie (Áine-Máire) Glynn

    Chief Operating Officer, Global Brain Health Institute (GBHI).

    Bridges scientific research and practical applications. Helped establish joint labs across Asia — including labs at NCBS/inStem — a strong model for international collaboration.”

    K. VijayRaghavan

    Professor Emeritus, NCBS; former Principal Scientific Adviser to the Government of India.

    “Very competent in collaboration agreements and negotiations… created a strong bridge between researchers in Japan and Italy.”

    Piero Carninci

    Head, Genomics Research Center, Human Technopole; President, HUGO (2025–2027).

    Your situation is not in this list. Let's talk about it.